Abstract
Bioactive glass has been shown to stimulate bone regeneration and soft tissue healing. In this study, we evaluated the local protective effects of bioactive glass on experimental gastric ulcers, in comparison with omeprazole and hydrotalcite. Single and multiple gavage of 45S5 bioactive glass dose-dependently protected stress ulcers in mice and chronic ulcers in rats. Multi-daily gavage of bioactive glass for 7 days prevented chronic ulcer recurrence by 50 %. Bioactive glass ionic dissolution produced marked proliferation of ethanol-injured GES-1 human gastric mucosa epithelial cells 48 and 72 h after exposure. Bioactive glass was shown to be hardly absorbed after single or multi-daily gavage. This study, for the first time, demonstrates that bioactive glass is effective in protecting against gastric ulcers, with its high efficacy comparable to omeprazole and superior to hydrotalcite. The lack of oral absorption makes bioactive glass a potential for treatment of peptic ulcers omitting systemic toxicity or side-effects.
Similar content being viewed by others
References
Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology. 2008;135(1):41–60.
Szabo S. Mechanisms of gastric mucosal injury and protection. J Clin Gastroenterol. 1991;13(Suppl 2):S21–34.
Walan A. Clinical experience with omeprazole: assessment of efficacy and safety. J Gastroenterol Hepatol. 1989;4(Suppl 2):27–33.
Holtermuller KH, Liszkay M, Bernard I, Haase W. Therapie des Ulcus ventriculi–Ein Vergleich zwischen dem niedrig dosierten Antazidum Hydrotalcit und Ranitidin–Ergebnisse einer randomisierten multizentrischen Doppelblindstudie. Talcivent Studiengruppe. Z Gastroenterol. 1992;30(10):717–21.
Tarnawski AS, Tomikawa M, Ohta M, Sarfeh IJ. Antacid talcid activates in gastric mucosa genes encoding for EGF and its receptor. The molecular basis for its ulcer healing action. J Physiol Paris. 2000;94(2):93–8.
Hench LL, Splinter RJ, Allen WC, Greenlee TK. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res. 1971;5(6):117–41.
Hu YC, Zhong JP. Osteostimulation of bioglass. Chin Med J (Engl). 2009;122(19):2386–9.
Jones JR, Lin S, Yue S, Lee PD, Hanna JV, Smith ME, et al. Bioactive glass scaffolds for bone regeneration and their hierarchical characterisation. Proc Inst Mech Eng H. 2010;224(12):1373–87.
Gosain AK. Bioactive glass for bone replacement in craniomaxillo facial reconstruction. Plast Reconstr Surg. 2004;114(2):590–3.
Ilharreborde B, Morel E, Fitoussi F, Presedo A, Souchet P, Penneçot GF, et al. Bioactive glass as bone substitute for spine fusion in adolescent idiopathic scoliosis. J Pediatr Orthop. 2008;28:347–51.
Gillette RL, Swaim SF, Sartin EA, Bradley DM, Coolman SL. Effects of a bioactive glass on healing of closed skin wounds in dogs. Am J Vet Res. 2001;62(7):1149–53.
Allan I, Newman H, Wilson M. Antibacterial activity of particulate bioglass against supra- and subgingival bacteria. Biomaterials. 2001;22(12):1683–7.
Hu S, Chang J, Liu M, Ning C. Study on antibacterial effect of 45S5 bioglass. J Mater Sci Mater Med. 2009;20(1):281–6.
Koller G, Roether J, Bruce K, Deb S. Antimicrobial potential of bioactive bone cements. J Appl Biomater Biomech. 2008;6(1):16–22.
Rectenwald JE, Minter RM, Rosenberg JJ, Gaines GC, Lee S, Moldawer LL. Bioglass attenuates a proinflammatory response in mouse peritoneal endotoxicosis. Shock. 2002;17(2):135–8.
Wang Y, Ma B, Xia ZF, Tang HT, Wang GY, Liu Y. The efficacy of bioglass on wound repair of the 30 cases of burn patients. Chin J Burns. 2006;22:474.
Ogino M, Ohuchi H, Hench L. Compositional dependence of the formation of calcium phosphate film on bioglass®. J Biomed Mater Res. 1980;14:55–64.
Kim C, Clark AE, Hench L. Early stages of calcium-phosphate layer formation in bioglasses. J Non Crystal Solids. 1988;113:195–202.
Hench LL. Bioceramics: from concept to clinic. J Am Ceram Soc. 1991;74:1487–510.
Zhong JP, Greenspan DC. Bioglass surface reactivity: from in vitro to in vivo. Bioceramics. 1998;11:415–8.
Zhong JP, Greenspan DC, Feng JW. A microstructural examination of apatite induced by bioglass in vitro. J Mater Sci Mater Med. 2002;13:321–6.
Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophysi Res Comm. 2000;276:461–5.
Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of bioglass 45S5 dissolution. J Biomed Mater Res. 2001;55(2):151–7.
Watanabe T, Higuchi K, Tominaga K, Fujiwara Y, Arakawa T. Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1beta. Gut. 2001;48(6):774–81.
Ma AN, Gong N, Lu JM, Huang JL, Hao B, Wang YX. The effect of bioglass 45S5 on prevention and treatment of experimental gastric ulcer. Chin J Pharmacol Toxicol. 2011;25(Suppl):115.
Wang ZB, Li JX, Zhu LQ, Niu FL, Cui W. Inhibiting effects of Panax notoginseng extracts on proliferation of GES-1 cells and MNNG-transformed GES-1 cells. Zhong Xi Yi Jie He Xue Bao. 2004;2(6):445–9.
Hayase M, Takeuchi K. Gastric acid secretion and lesion formation in rats under water-immersion stress. Dig Dis Sci. 1986;31(2):166–71.
Takagi K, Okabe S, Saziki R. A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing. Jpn J Pharmacol. 1969;19(3):418–26.
Bullock S, Johnston EE, Willson T, Gatenholm P, Wynne KJ. Surface science of a filled polydimethylsiloxane-based alkoxysilane-cured elastomer: RTV11. J Colloid Interface Sci. 1999;210(1):18–36.
Wang YX, Pang CC. Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase. J Pharmacol Exp Ther. 1993;265(1):263–72.
Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury. 2005;36(Suppl 3):S20–7.
Henke PG. Recent studies of the central nucleus of the amygdala and stress ulcers. Neurosci Biobehav Rev. 1988;12(2):143–50.
Okabe S, Amagase K. An overview of acetic acid ulcer models and their utility for drug screening. Nippon Yakurigaku Zasshi. 2003;122(1):73–92.
Day RM. Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro. Tissue Eng. 2005;11(5–6):768–77.
Jell G, Stevens MM. Gene activation by bioactive glasses. J Mater Sci Mater Med. 2006;17(11):997–1002.
Asselin A, Hattar S, Oboeuf M, Greenspan D, Berdal A, Sautier JM. The modulation of tissue-specific gene expression in rat nasal chondrocyte cultures by bioactive glasses. Biomaterials. 2004;25(25):5621–30.
Christodoulou I, Buttery LD, Saravanapavan P, Tai G, Hench LL, Polak JM. Dose- and time-dependent effect of bioactive gel-glass ionic-dissolution products on human fetal osteoblast-specific gene expression. J Biomed Mater Res B Appl Biomater. 2005;74(1):529–37.
Day R, Boccaccini AR, Shurey S, Roether JA, Forbes A, Hench LL, Gabe SM. Assessment of polyglycolic acid mesh and bioactive glass for soft tissue engineering scaffolds. Biomaterials. 2004;25(27):5857–66.
Franko TG, Richter JE. Proton-pump inhibitors for gastric acid-related disease. Cleve Clin J Med. 1998;65(1):27–34.
Cundy T, Mackay J. Proton pump inhibitors and severe hypomagnesaemia. Curr Opin Gastroenterol. 2011;27(2):180–5.
Kuipers MT, Thang HD, Arntzenius AB. Hypomagnesaemia due to use of proton pump inhibitors: a review. Neth J Med. 2009;67(5):169–72.
Gouraud A, Vochelle V, Descotes J, Vial T. Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole. Clin Drug Investig. 2010;30(8):559–63.
Lindquist M, Edwards IR. Endocrine adverse effects of omeprazole. BMJ. 1992;305(6851):451–2.
Carvajal A, Martin Arias LH. Gynecomastia and sexual disorders after the administration of omeprazole. Am J Gastroenterol. 1995;90(6):1028–9.
Carvajal A, Macias D, Gutierrez A, Ortega S, Sainz M, Martin Arias LH, et al. Gynaecomastia associated with proton pump inhibitors: a case series from the Spanish pharmacovigilance system. Drug Saf. 2007;30(6):527–31.
Acknowledgments
This work is financially supported in part by Changzhou Beiersheng Biotech Co. Ltd, Changzhou, China.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ma, An., Gong, N., Lu, Jm. et al. Local protective effects of oral 45S5 bioactive glass on gastric ulcers in experimental animals. J Mater Sci: Mater Med 24, 803–809 (2013). https://doi.org/10.1007/s10856-012-4844-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-012-4844-7